Invention Grant
- Patent Title: Use of 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to prevent secondary hyperparathyroidism or the symptoms thereof
-
Application No.: US14947142Application Date: 2015-11-20
-
Publication No.: US09717744B2Publication Date: 2017-08-01
- Inventor: Hector F. DeLuca , Lori A. Plum , Julia B. Zella , Margaret Clagett-Dame
- Applicant: Wisconsin Alumni Research Foundation
- Applicant Address: US WI Madison
- Assignee: Wisconsin Alumni Research Foundation
- Current Assignee: Wisconsin Alumni Research Foundation
- Current Assignee Address: US WI Madison
- Agency: Andrus Intellectual Property Law, LLp
- Main IPC: A61K31/593
- IPC: A61K31/593
Abstract:
Disclosed are methods of administering 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 to treat and/or prevent secondary hyperparathyroidism and/or its accompanying symptoms in a subject having or at risk for developing secondary hyperparathyroidism.
Public/Granted literature
- US20160136184A1 Use of 2-Methylene-19-Nor-(20S)-1alpha,25-Dihydroxyvitamin D3 to Treat Secondary Hyperparathyroidism Public/Granted day:2016-05-19
Information query
